Indications and uses
for the temporary relief of these symptoms associated with menstrual periods: cramps bloating water-weight gain headache backache muscle aches fatigue
for the temporary relief of these symptoms associated with menstrual periods: cramps bloating water-weight gain headache backache muscle aches fatigue
do not take more than the recommended dose adults and children 12 years and older: take 2 caplets with water repeat every 6 hours, as needed do not exceed 6 caplets per day children under 12 years: consult a doctor
store at room temperature
Drug Facts
| Active ingredients (in each caplet) | Purpose |
|---|---|
| Acetaminophen 500 mg | Pain reliever |
| Caffeine 60 mg | Diuretic |
| Pyrilamine maleate 15 mg | Antihistamine |
for the temporary relief of these symptoms associated with menstrual periods:
This product contains acetaminophen. Severe liver damage may occur if you take
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
store at room temperature
carnauba wax, croscarmellose sodium, FD&C blue #2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, pregelatinized starch, propylene glycol, shellac, titanium dioxide, triacetin
1-800-331-4536(Mon-Fri 9AM - 5PM EST) or
www.midol.com
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0655708118412 | GTIN-13: 0655708118412 EAN-13: 0655708118412 GTIN-12: 655708118412 UPC-A: 655708118412 GTIN storage (14 digits): 00655708118412 | 2511841100 - Midol - 1841-1.jpg |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0280-8005-16 | EA - Each | 0280-8005 | dcbec074-9880-48e9-96d8-049649c185be | 1 | 2018-04-19 |
| 0280-8005-24 | EA - Each | 0280-8005 | eaea4dec-a037-41d2-b348-b5491e1f1199 | 1 | 2018-04-19 |
| 0280-8005-40 | EA - Each | 0280-8005 | 7092f7e0-408c-4e14-a65c-d4ba66cb33dd | 1 | 2016-02-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85237-1841 | 85237-1841-1, 85237-1841-2, 85237-1841-3, 85237-1841-4, 85237-1841-5 |
| 0280-8005 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C BLUE NO. 2 | L06K8R7DQK | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SHELLAC | 46N107B71O | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| CAFFEINE | 3G6A5W338E | ACTIB |
| PYRILAMINE MALEATE | R35D29L3ZA | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 2 | 2025-12-27 | full-release | 2026-06-01 01:28:53 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Midol Complete | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Select Consumer Group | 3ca96ed9-d9af-dbfe-e063-6394a90a2932 | 2026-07-03 | Warnings | 85237-1841-1 85237-1841-2 85237-1841-4 85237-1841-3 85237-1841-5 85237-1841 85237184104 85237184101 85237184105 85237184103 85237184102 55bc3945-3864-e797-e063-6394a90a2f87 3ca96ed9-d9af-dbfe-e063-6394a90a2932 |
| Midol Complete | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Bayer HealthCare LLC. | ce9e6acb-a38b-4c9b-a7e8-3e1c2a49a324 | 2025-04-10 | Warnings | 0280-8005 |
Adverse event summaries are temporarily unavailable. Other product information remains available.